Andexanet alfa: a recombinant mimetic of human factor Xa for the reversal of anticoagulant therapies.
Ginés Escolar Albadalejo, Maribel Díaz Ricart, Eduardo Arellano Rodrigo
págs. 271-282
Brodalumab: the first anti-IL-17 receptor agent for psoriasis.
L. Puig
págs. 283-298
Cabozantinib use in renal cell carcinoma.
E. A. Neuwelt, S. Mathur, T.A. Johnson, Elizabeth R. Kessler, Daniel W. Bowles
págs. 299-308
American Academy of Neurology – 69th Annual Meeting (April 22-28, 2017 - Boston, Massachusetts, USA).
Coia Dulsat
págs. 309-320
New product intros (avelumab; baricitinib; dupilumab; gallium-68 edotreotide; Hexavalent vaccine; plecanatide; ribociclib).
pág. 321
© 2001-2024 Fundación Dialnet · Todos los derechos reservados
Coordinado por: